Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Eng Liu

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Future Microbiology|September 4, 2024
Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 yearStefan Esser, Alexy Inciarte, Itzchak Levy, et al.
HIV Medicine|December 27, 2023
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohortsStefan Esser, Jason Brunetta, Alexy Inciarte, et al.
Infectious Diseases and Therapy|May 31, 2021
Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter StudySung-Hsi Huang, Chun-Yuan Lee, Chin-Shiang Tsai, et al.
The American Journal of Gastroenterology|March 5, 2009
Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccinationHsin-Yun Sun, Wen-Chien Ko, Jih-Jin Tsai, et al.
Plos One|February 22, 2017
Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in TaiwanPei-Ying Wu, Chien-Yu Cheng, Chun-Eng Liu, et al.
Emerging Microbes & Infections|January 20, 2022
Changing epidemiology of shigellosis in Taiwan, 2010-2019: an emerging threat to HIV-infected patients and men who have sex with menChin-Shiang Tsai, Kuan-Yin Lin, Bo-Huang Liou, et al.
Journal of Infection and Public Health|June 4, 2023
A new collaborative care approach toward hepatitis C elimination in marginalized populationsWei-Wen Su, Chih-Chao Yang, Rene Wei-Jung Chang, et al.
Plos One|March 17, 2018
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in TaiwanChia-Wen Li, Chia-Jui Yang, Hsin-Yun Sun, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010Han-Siong Toh, Yin-Ching Chuang, Chi-Chang Huang, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010Yu-Lin Lee, Yao-Shen Chen, Han-Siong Toh, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Future Microbiology|September 4, 2024
Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 yearStefan Esser, Alexy Inciarte, Itzchak Levy, et al.
HIV Medicine|December 27, 2023
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohortsStefan Esser, Jason Brunetta, Alexy Inciarte, et al.
Infectious Diseases and Therapy|May 31, 2021
Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter StudySung-Hsi Huang, Chun-Yuan Lee, Chin-Shiang Tsai, et al.
The American Journal of Gastroenterology|March 5, 2009
Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccinationHsin-Yun Sun, Wen-Chien Ko, Jih-Jin Tsai, et al.
Plos One|February 22, 2017
Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in TaiwanPei-Ying Wu, Chien-Yu Cheng, Chun-Eng Liu, et al.
Emerging Microbes & Infections|January 20, 2022
Changing epidemiology of shigellosis in Taiwan, 2010-2019: an emerging threat to HIV-infected patients and men who have sex with menChin-Shiang Tsai, Kuan-Yin Lin, Bo-Huang Liou, et al.
Journal of Infection and Public Health|June 4, 2023
A new collaborative care approach toward hepatitis C elimination in marginalized populationsWei-Wen Su, Chih-Chao Yang, Rene Wei-Jung Chang, et al.
Plos One|March 17, 2018
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in TaiwanChia-Wen Li, Chia-Jui Yang, Hsin-Yun Sun, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010Han-Siong Toh, Yin-Ching Chuang, Chi-Chang Huang, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010Yu-Lin Lee, Yao-Shen Chen, Han-Siong Toh, et al.
Pageof 8